Trial · NCT07878273
Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis
NCT07878273, Recruiting, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis. Trials, record NCT07878273. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07878273
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis
- NCT number
- NCT07878273
- Status
- Recruiting
- Enrollment
- 102 participants, estimated
- Lead sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Conditions
- Plantar Fasciitis, Chronic, Tibial Nerve
- Interventions
- Pressure Pain Threshold Assessment, Plantar fascia ultrasonographic Assessment, Tibial nerve ultrasonographic assessment
- First posted
- 2026-10-16
- Last updated
- 2026-10-16
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Assessment of tibial nerve cross-sectional area with ultrasonographic evaluation | baseline | The tibial nerve image will be obtained from within the tarsal tunnel and will be visualised by holding it with a prop at minimum pressure next to the medial malleolus, under the flexor retinaculum, alongside the artery-venous bundle. Three measurements will be taken for the nerve cross-sectional area, and the mean will be calculated. An independent researcher will code and record all obtained images, and the images will be analysed using the ImageJ offline DICOM software 1.8 ® (National Institute of Health, Bethesda, MD, USA, v.1.53a). |
| Secondary | Pressure Pain Threshold - calcaneus | Baseline | Pressure pain threshold is defined as the minimal pressure level that causes pain. The measurement will be applied twice with a 1-minute interval, and the average of these applications will be recorded. A trial test will be conducted on the patient before the actual test. Pressure will be applied with a pressure algometer until pain is induced, and the test will be terminated when the patient feels pain. The measurement will be taken from the calcaneus bone (the attachment point of the plantar fascia) using a Wagner manual pressure algometer (1 cm² probe-10 kg/20 lb). |
| Secondary | Numeric Pain Rating Scale, NPRS | baseline | Pain severity will be evaluated using a scale rated from 0 (no pain) to 10 (unbearable pain). Participants will be asked to rate the pain felt with the first step after waking up in the morning and the average pain level over the past week. |
| Secondary | Foot Posture Index | baseline | The participant's foot will be observationally scored based on six anatomical criteria in a standing natural posture, and the total score will be recorded. |
| Secondary | Short Form-12 (SF-12) | Baseline | Physical Component Summary and Mental Component Summary |
| Secondary | Foot Function Index | baseline | The Foot Function Index is a self-report-based scale developed to evaluate the effects of foot and ankle-related problems on pain, functional limitation, and daily life activities in individuals, with its validity and reliability demonstrated. FFI consists of three sub-dimensions: pain, disability (functional limitation), and activity limitation. The scale allows individuals to evaluate foot-related problems they have experienced recently in the context of daily life activities. Each sub-dimension and total score reflect the level of impairment in foot functions. Increasing FFI scores indicate that the severity of foot pain and the limitations in foot functions have increased, thereby negatively affecting foot-related quality of life. FFI is widely used in clinical and research settings to evaluate the functional effects of foot pathologies. |
| Secondary | Thickness of the plantar fascia in ultrasonographic imaging | Baseline | In the study, the evaluation with ultrasound will be conducted while the participants are in a prone position on the examination table, with their feet hanging off the table and in a dorsiflexed position. A linear probe will be placed longitudinally over the medial tubercle of the calcaneus to ultrasonographically examine the plantar fascia thickness (PFT). PFT will be measured 1 cm distal to the calcaneus attachment point. A PFT of 4 mm or greater will be considered evidence of fasciitis. It has been shown that this measurement technique has good intra-rater reliability. The Sonosite M-Turbo device will be used for ultrasonography and will be performed by a physical therapy and rehabilitation specialist with 10 years of experience. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07878273
GET https://conductscience.org/api/trials/v1/NCT07878273/registered